Course Description: Despite the efficacy of chemo-immuno-therapy combination regimens for chronic and acute leukaemia, obstacles remain, and the negative effects of these regimens might lead to treatment termination. While leukemic therapies have improved over the previous decade, research into approaches that may expand combination approaches as well as finite treatment intervals while giving less adverse effects, increased adherence, and access is underway. Clinicians must evaluate patient-specific considerations while using currently recommended regimens that contain BTK and BCL-2 inhibitors. Expert panels will conduct a conversation concentrating on the problems facing both the healthcare system and people with CLL, including adverse effects, growing treatment options, a combination of IV and oral regimens, and economic burden, in this continuation of material from the AMCP Annual Meeting. Case-studies reviewed by the faculty panel will include specific suggestions for managing the burgeoning arsenal of regimens for CLL patients, formulary management, and resource utilization strategies.
Target audience: Oncology/Haematology-Health-system/ Health-Care Providers
Type of activity: Application Faculty:
Release date:
Expiration date:
Time to complete activity: Self-pace
Fee:
Objectives of Education:
Participants will be capable of performing the following tasks after completing this activity:
⇒ When assessing treatment plans for patients with chronic lymphocytic leukemia, employ the most recent clinical data (CLL).
⇒ Explore managed care strategies for improving the clinical results in CLL treatment.
Educational Disclaimer: CME activities don't count as professional advice or referrals; they are only offered for educational content. Discussions on medications, dosing, and procedures may have relied on the author(s)' clinical experience, professional literature, or other sources. They may also point to exploratory applications that lack official labelling or indications. Participants are advised to refer to authoritative sources or in-depth prescription information websites.